SCHEMBL3942298

SCHEMBL3942298

COC(=O)c1cccc(C#CC(C)(C)O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.47
▸ ALDH1A1 P00352 4/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ LOXL2 Q9Y4K0 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ TSHR P16473 1/20 0.44
▸ HAO1 Q9UJM8 1/20 0.44
▸ CYP4F2 P78329 2/20 0.44
▸ CYP4A11 Q02928 2/20 0.44
▸ RAB9A P51151 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ EGFR P00533 1/20 0.43
▸ MRGPRX4 Q96LA9 1/20 0.42
▸ NPC1 O15118 1/20 0.41
▸ MAPT P10636 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3929847 0.83 HAO1 (0.50) LMNAHAO1CYP1A2CYP2C9
SCHEMBL1637624 0.83 ACACB (0.46) LMNAALDH1A1L3MBTL1TSHRHAO1
SCHEMBL10411912 0.82 ALDH1A1 (0.52) ALDH1A1CYP3A4MAPK1LOXL2TSHR
SCHEMBL16719850 0.82 GABRA1 (0.53) ALDH1A1CYP3A4MAPK1LOXL2TSHR
SCHEMBL3121665 0.81 GRM5 (0.50) LMNATSHRHAO1
SCHEMBL22031725 0.81 LMNA (0.59) LMNAALDH1A1LOXL2L3MBTL1TSHR
SCHEMBL4672150 0.81 ALDH1A1 (0.51) ALDH1A1CYP3A4MAPK1LOXL2TSHR
SCHEMBL1926585 0.81 TSHR (0.60) LMNAALDH1A1CYP3A4MAPK1LOXL2
SCHEMBL1637026 0.80 L3MBTL1 (0.52) LMNAALDH1A1CYP3A4MAPK1L3MBTL1
SCHEMBL16720308 0.80 KDM4E (0.55) ALDH1A1CYP3A4MAPK1LOXL2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831198-B1 PYRIDINE CARBOXAMIDE DERIVATIVES FOR USE AS ANTICANCER AGENTS ASTRAZENECA AB (SE) 2009-04-08 — — EP disclosed
Send feedback